EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Barnesiella intestinihominis improves gut microbiota disruption and intestinal barrier integrity in mice with impaired glucose regulation

Xiaojia Liu, Ling Wang, Bing Huang, Yi Jiao, Yaqun Guan, Rebiya Nuli

Frontiers in Pharmacology · 08.10.2025 · 16

DOI: 10.3389/fphar.2025.1635579 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 08.10.2025. Verfasst von Xiaojia Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Parasitology, School of Basic Medical Sciences, Xinjiang Medical University, Urumqi, Xinjiang, China. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Impaired glucose regulation (IGR) is a prediabetic state closely associated with gut microbiota dysbiosis. Our previous metagenomic analysis identified a significant deficiency of Barnesiella intestinihominis ( B. intestinihominis ) in IGR patients ( p < 0.01). The present study was therefore designed to investigate the therapeutic potential of B. intestinihominis supplementation in a high-fat diet (HFD)-induced IGR mouse model and to explore its potential mechanisms of action.

Methods

A mouse model of IGR was established by HFD. The treatment group received a daily supplementation of live B. intestinihominis (1×10 8 CFU) for 5 weeks. Gut microbiota composition was analyzed. Colonic expression levels of tight junction proteins (ZO-1 and occludin) and cytokines (IL-10, TNF-α, IL-6) were measured. In vitro experiments using Caco-2 human intestinal epithelial cells were conducted to assess the direct effects of B. intestinihominis . B. intestinihominis fermentation broth, heat-inactivated bacterial solution, and bacterial solution were co-cultured with Caco-2 cells. Cell viability was assessed using the CCK-8 assay, and the expression levels of tight junction proteins were evaluated. Trans-epithelial electrical resistance (TEER) and alkaline phosphatase activity were also assessed in the Caco-2 model.

Results

Daily supplementation with B.intestinihominis significantly attenuated HFD-induced hyperglycemia in mice. It also modulated the gut microbiota, evidenced by an increased abundance of beneficial Ligilactobacillus and a reduction in pathogenic Lachnoclostridium . Furthermore, B. intestinihominis administration upregulated the expression of colonic tight junction proteins (ZO-1 and occludin) and the anti-inflammatory cytokine IL-10, while simultaneously inhibiting the pro-inflammatory mediators TNF-α and IL-6. In vitro , the fermentation broth of B.intestinihominis (10%) increased Caco-2 cell viability, and heat-inactivated bacteria (1×10 7 CFU) enhanced ZO-1 expression. However, neither treatment significantly affected trans-epithelial electrical resistance (TEER) nor alkaline phosphatase activity in Caco-2 cells.

Discussion

These findings suggest that intestinal probiotics B. intestinihominis may ameliorate IGR by modulating the gut microbiota, enhancing intestinal barrier integrity, and attenuating inflammation, thus supporting their potential as a therapeutic intervention for metabolic disorders.

Schlagwörter

Stichwörter der Autor:innen

Barnesiella intestinihominisgut microbiotaimpaired glucose regulationinsulin resistanceintestinal barrier

Autor:innen und Institutionen

  • Department of Human Parasitology, School of Basic Medical Sciences, Xinjiang Medical University, Urumqi, Xinjiang, China.
  • Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Xinjiang Medical University, Urumqi, Xinjiang, China.
  • Xinjiang Key Laboratory of Molecular Biology for Endemic Disease, Xinjiang Medical University, Urumqi, Xinjiang, China.

Zitieren

APA

Liu, X., Wang, L., Huang, B., Jiao, Y., Guan, Y., & Nuli, R. (2025). Barnesiella intestinihominis improves gut microbiota disruption and intestinal barrier integrity in mice with impaired glucose regulation. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1635579

Vancouver

Liu X, Wang L, Huang B, Jiao Y, Guan Y, Nuli R. Barnesiella intestinihominis improves gut microbiota disruption and intestinal barrier integrity in mice with impaired glucose regulation. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1635579

BibTeX
@article{Liu2025,
  author = {Liu, Xiaojia and Wang, Ling and Huang, Bing and Jiao, Yi and Guan, Yaqun and Nuli, Rebiya},
  title = {Barnesiella intestinihominis improves gut microbiota disruption and intestinal barrier integrity in mice with impaired glucose regulation},
  journal = {Frontiers in Pharmacology},
  year = {2025},
  volume = {16},
  doi = {10.3389/fphar.2025.1635579}
}
Kostenlos starten →